Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

240 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The homeodomain-containing proteins: an update on their interacting partners.
Chariot A, Gielen J, Merville MP, Bours V. Chariot A, et al. Among authors: bours v. Biochem Pharmacol. 1999 Dec 15;58(12):1851-7. doi: 10.1016/s0006-2952(99)00234-8. Biochem Pharmacol. 1999. PMID: 10591139 Review.
Can NF-kappaB be a target for novel and efficient anti-cancer agents?
Olivier S, Robe P, Bours V. Olivier S, et al. Among authors: bours v. Biochem Pharmacol. 2006 Oct 30;72(9):1054-68. doi: 10.1016/j.bcp.2006.07.023. Epub 2006 Sep 14. Biochem Pharmacol. 2006. PMID: 16973133 Review.
Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
Olivier S, Close P, Castermans E, de Leval L, Tabruyn S, Chariot A, Malaise M, Merville MP, Bours V, Franchimont N. Olivier S, et al. Among authors: bours v. Mol Pharmacol. 2006 May;69(5):1615-23. doi: 10.1124/mol.105.020479. Epub 2006 Feb 23. Mol Pharmacol. 2006. PMID: 16497877
TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.
Bonif M, Meuwis MA, Close P, Benoit V, Heyninck K, Chapelle JP, Bours V, Merville MP, Piette J, Beyaert R, Chariot A. Bonif M, et al. Among authors: bours v. Biochem J. 2006 Mar 15;394(Pt 3):593-603. doi: 10.1042/BJ20051659. Biochem J. 2006. PMID: 16336209 Free PMC article.
Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.
Viatour P, Merville MP, Bours V, Chariot A. Viatour P, et al. Among authors: bours v. Trends Biochem Sci. 2005 Jan;30(1):43-52. doi: 10.1016/j.tibs.2004.11.009. Trends Biochem Sci. 2005. PMID: 15653325 Review.
Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expression.
Benoit V, Chariot A, Delacroix L, Deregowski V, Jacobs N, Merville MP, Bours V. Benoit V, et al. Among authors: bours v. Cancer Res. 2004 Apr 15;64(8):2684-91. doi: 10.1158/0008-5472.can-03-2914. Cancer Res. 2004. PMID: 15087380
Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.
Viatour P, Legrand-Poels S, van Lint C, Warnier M, Merville MP, Gielen J, Piette J, Bours V, Chariot A. Viatour P, et al. Among authors: bours v. J Biol Chem. 2003 Nov 21;278(47):46541-8. doi: 10.1074/jbc.M306381200. Epub 2003 Sep 12. J Biol Chem. 2003. PMID: 12972430
NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets.
Chariot A, Meuwis MA, Bonif M, Leonardi A, Merville MP, Gielen J, Piette J, Siebenlist U, Bours V. Chariot A, et al. Among authors: bours v. Curr Med Chem. 2003 Apr;10(7):593-602. doi: 10.2174/0929867033457926. Curr Med Chem. 2003. PMID: 12678791 Review.
Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C, Berkhout B, Castellano R, de Launoit Y, Burny A, Piette J, Bours V, Van Lint C. Quivy V, et al. Among authors: bours v. J Virol. 2002 Nov;76(21):11091-103. doi: 10.1128/jvi.76.21.11091-11103.2002. J Virol. 2002. PMID: 12368351 Free PMC article.
Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling.
Meuwis MA, Fillet M, Geurts P, de Seny D, Lutteri L, Chapelle JP, Bours V, Wehenkel L, Belaiche J, Malaise M, Louis E, Merville MP. Meuwis MA, et al. Among authors: bours v. Biochem Pharmacol. 2007 May 1;73(9):1422-33. doi: 10.1016/j.bcp.2006.12.019. Epub 2006 Dec 20. Biochem Pharmacol. 2007. PMID: 17258689
240 results
Jump to page